Brain Tumors Research - Symptoms, Benign and Malignant Tumors, Gliomas, Screening, Treatment

Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment.


Brain Tumors Research Today

Home

View Latest Issue

Information About Brain Tumors

Books on Brain Tumors

Advertising in Research Today

View Other Research Today Publications



Volume 3 (2006), Issue 10 (October)

  1. RPA classification has prognostic significance for surgically resected single brain metastasis.
    Int J Radiat Oncol Biol Phys, 66(3): 810-7. [Abstract] [Full-text]
  2. Five-year survivors of brain metastases: a single-institution report of 32 patients.
    Int J Radiat Oncol Biol Phys, 66(3): 801-9. [Abstract] [Full-text]
  3. Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.
    Int J Radiat Oncol Biol Phys, 66(3): 818-24. [Abstract] [Full-text]
  4. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
    Int J Cancer, 119(10): 2330-8. [Abstract] [Full-text]
  5. Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells.
    Br J Cancer, 95(7): 879-88. [Abstract] [Full-text]
  6. Fatty acid synthase: a novel target for antiglioma therapy.
    Br J Cancer, 95(7): 869-78. [Abstract] [Full-text]
  7. Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.
    Br J Cancer, 95(7): 862-8. [Abstract] [Full-text]
  8. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.
    BMC Cancer, 6: 226. [Abstract] [Full-text]
  9. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy.
    J Clin Oncol, 24(29): 4758-63. [Abstract] [Full-text]
  10. Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes.
    J Clin Oncol, 24(29): 4754-7. [Abstract] [Full-text]
  11. Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.
    J Clin Oncol, 24(29): 4746-53. [Abstract] [Full-text]
  12. Amygdaloid lesion-induced obesity: relation to sexual behavior, olfaction, and the ventromedial hypothalamus.
    Am J Physiol Regul Integr Comp Physiol, 291(5): R1201-14. [Abstract] [Full-text]
  13. Metastases to the pineal gland.
    Neurology, 67(7): 1303-4. [Abstract] [Full-text]
  14. Central nervous system borreliosis mimicking a pontine tumour.
    J Med Microbiol, 55: 1597-9. [Abstract] [Full-text]
  15. A case series of pediatric primary central nervous system lymphoma: favorable outcome without cranial irradiation.
    Pediatr Blood Cancer, 47(7): 880-5. [Abstract] [Full-text]
  16. Changes in liver mitochondrial plasticity induced by brain tumor.
    BMC Cancer, 6: 234. [Abstract] [Full-text]
  17. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: a double-blind, randomized and placebo-controlled study.
    Br J Anaesth, 97(5): 658-65. [Abstract] [Full-text]
  18. Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas.
    Neurosurgery, 59(4): 902-9; discussion 909-10. [Abstract] [Full-text]
  19. Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.
    Br J Cancer, 95(8): 991-7. [Abstract] [Full-text]
  20. Pitfalls in the diagnosis of brain tumours.
    Lancet Neurol, 5(11): 937-48. [Abstract] [Full-text]
  21. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Mol Pharmacol, 70(5): 1524-33. [Abstract] [Full-text]
  22. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    BMC Cancer, 6: 247. [Abstract] [Full-text]
  23. Late response to radiochemotherapy in pediatric glioblastoma: report on two patients treated according to HIT-GBM protocols.
    Pediatr Hematol Oncol, 23(8): 631-7. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Brain Tumors Research Today. All Rights Reserved.



Brain Tumors Research Today Archive:

Volume 1 (2004)
  Issue 1 (August)
  Issue 2 (September)
  Issue 3 (October)
  Issue 4 (November)
  Issue 5 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)



Brain Tumors Books

Never Change

Never Change